Entity > Corporation > US > New York City New York > Synlogic

About Synlogic

Synlogic is a clinical-stage biotechnology company developing drugs for metabolic and immunological diseases using its proprietary synthetic technology approach.

Synlogic Targets Areas of Unmet Medical Needs: Synlogic specifically targets four areas of unmet medical need: rare metabolic diseases, enteric hyperoxaluria, gout, and immunological and inflammatory diseases The company's lead programs target patients with rare genetic metabolic diseases such as phenylketonuria and secondary hyperoxaluria.

Collaborations and Partnerships: Synlogic is also collaborating with Roche in a research collaboration focused on the discovery of a novel synthetic biologic for the treatment of inflammatory bowel disease, and with Ginkgo Bioworks to include additional unpublished preclinical assets, combining Synlogic's approach to synthetic biotics with Ginkgo's codebase and foundry services.

Founded in 2014 by Synthetic Biology Experts: Synlogic was founded in 2014 by two of the world's leading synthetic biology experts, James Collins, PhD, and Tim Lu, MD, PhD, of the Massachusetts Institute of Technology. The company is made up of visionary scientists - pioneering biologists and genetic engineers working to transform drug discovery and disease treatment in a new way. Synlogic combines synthetic biology, a form of precision biological engineering, with the principles of traditional drug discovery to develop medicines for diseases that require new approaches.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Synlogic

Company Attribute Value
Name Synlogic
Url synlogictx
Wikipedia wikipedia
Google google
Wikidata wikidata



New York City, US
4 Sep 2023

New York City, US
4 Sep 2023


Page: 1 Desktop | Laptop Devices
Synlogic Therapeutics: Home
Synlogic is the leading company advancing therapeutics based on synthetic biology, working at the intersection of biology and engineering to treat disease. › quote › SYBX
Synlogic, Inc. (SYBX) Stock Price, News, Quote & History
Find the latest Synlogic, Inc. (SYBX) stock quote, history, news and other vital information to help you with your stock trading and investing. › symbol › SYBX
Synlogic, Inc. (SYBX) Stock Price Today, Quote & News
6 days ago — Synlogic, Inc.'s stock symbol is SYBX and currently trades under NASDAQ. It's current price per share is approximately $0.50. What are your ... › synlogic-therapeutics
Oct 22, 2021 — Synlogic | 8824 followers on LinkedIn. Designed for Life | Synlogic is a clinical-stage biotechnology company advancing novel, oral, ... › Market Activity › Stocks
Synlogic, Inc. Common Stock (SYBX)
Synlogic, Inc. Common Stock (SYBX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. › synlogic_tx
Synlogic (@synlogic_tx) / X
Synlogic is a clinical-stage biotech company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases. › quote › SYBX:US
SYBX: Synlogic Inc Stock Price Quote - NASDAQ CM
Synlogic, Inc. operates as a pharmaceutical company. The Company develops synthetic biotic medicines for inflammatory bowel diseases, cancer, ... › organization › synlogic
Synlogic - Crunchbase Company Profile & Funding
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
Related Searches
Related Searches
synlogic pku
synlogic careers
synlogic therapeutics
Knowledge Panel
Knowledge Panel

Synlogic (Biotech company)

Synlogic is a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases in need of new treatment options.,need%20of%20new%20treatment%20options.
  • Stock price : SYBX (NASDAQ) $0.47 -0.02 (-3.86%)Sep 1, 4:00 PM EDT - Disclaimer
  • Headquarters : Massachusetts
  • Founded : 2014

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193744